Monsanto licenses use of Cellectis' genome modification technology
Monsanto Company announced a non-exclusive research and commercial license agreement with Cellectis S.A. for broad use of its meganuclease technology in plants.
Meganucleases are molecular scissors that can be directed to a single site in the genome of a plant cell, thereby allowing a wide range of precise genome modifications, including gene stacking, gene knock-out as well as modulation of gene function to develop new traits. Under the agreement, Monsanto will have access to Cellectis’ intellectual property on meganucleases and its custom meganuclease production platform.
Cellectis will receive an upfront payment of €3 million, and subject to the approval of the Extraordinary General Meeting of Cellectis’ shareholders, Monsanto will make an equity investment of €1 million to allow Cellectis to scale the technology for agriculture. Cellectis will also be eligible to receive fees for the development of each meganuclease, success-based milestones and may receive royalties on certain traits commercialized by Monsanto. Further financial details of the agreement were not disclosed.
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents

Canine Diag’noses’ - Dogs can detect SARS-CoV-2 infected humans on all tested body fluids with high accuracy
Got good fat?

Ultrafast lasers protect adenine - Ultrafast lasers can protect DNA building block from light-induced dissociation

How can we fight blood cancer more effectively? - Several hundred different treatment combinations to be tested simultaneously outside the body

B Medical Systems S.à r.l. - Hosingen, Luxembourg

New imaging analysis method revolutionizes the diagnosis of head and neck tumors

Scientific Paradox: Phosphate Increases The Concentration of Sodium (!) in The Blood
BASF Plant Science takes Amflora case to EU Court - BASF filed action against the EU Commission for failure to act

A double ring ceremony prepares telomerase RNA to wed its protein partner

Using light to produce medication and plastics more efficiently - How the energy efficiency of photochemical reactions can be increased tenfold
AMT's Lead Product Poised to Address Major Liver Disease - European Patent Office Grants Patent for Treatment of Non-alcoholic Steatotic Hepatitis
